Search

everythinglearnresearchcommunity

for

Search:↓

Calcium signals and SHH guide the direction of feather growth in chicken skin.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

FFA has higher long-term remission rates than LPP.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

New treatments for severe alopecia areata show promise but lack standard approval.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Certain Chinese herbs may help treat kidney fibrosis by targeting TGF-β.

CD2 might be a new treatment target for patchy alopecia areata.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.